This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Cedars-Sinai Medical Center. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Yunguang Tong: Innovator in Cancer Treatment Biomarkers
Introduction
Yunguang Tong is a notable inventor based in Los Angeles, CA, who has made significant contributions to the field of cancer treatment. His innovative work focuses on the use of biomarkers to enhance the diagnosis and treatment of cancer.
Latest Patents
Yunguang Tong holds a patent for the use of pituitary tumor transforming gene 1 (PTTG1) as a biomarker for diagnosing cancer and determining treatment responsiveness. This invention outlines a method for treating cancer by inhibiting the expression of PTTG1 and administering a therapeutically effective amount of Aurora kinase inhibitor, HDAC inhibitor, and/or ROS-generating agent.
Career Highlights
Yunguang Tong is affiliated with Cedars-Sinai Medical Center, where he continues to advance research in cancer treatment. His work has the potential to significantly impact how cancer is diagnosed and treated, providing new avenues for patient care.
Collaborations
Yunguang collaborates with Shlomo Melmed, enhancing the research efforts at Cedars-Sinai Medical Center.
Conclusion
Yunguang Tong's innovative approach to cancer treatment through the use of biomarkers exemplifies the critical role of inventors in advancing medical science. His contributions are paving the way for improved diagnostic and therapeutic strategies in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile